Fragmin Safety And Efficacy In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism And Extended Thromboprophylaxis In Cancer Patients In Slovakia (An Open, Prospective, Non-Comparative Study.

Trial Profile

Fragmin Safety And Efficacy In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism And Extended Thromboprophylaxis In Cancer Patients In Slovakia (An Open, Prospective, Non-Comparative Study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Jul 2010

At a glance

  • Drugs Dalteparin sodium (Primary)
  • Indications Deep vein thrombosis; Pulmonary embolism
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 23 Jun 2009 Actual patient number (89) added as reported by ClinicalTrials.gov.
    • 23 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Apr 2009 Status change from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top